Staging for
nonmelanoma skin cancer is based on the size of the
cancer, lymph node involvement, and the involvement of underlying structures,
such as muscle or bone. Staging of nonmelanoma skin cancer has been classified
by the American Joint Committee on Cancer (AJCC).1
- TX: Primary tumor cannot be assessed.
- T0: No evidence of primary tumor.
- Tis: Cancer at this
stage is contained in the skin lesion (in situ).
- T1: Tumor is
2 cm (0.8 in.) or
smaller.
- T2: Tumor is larger than
2 cm (0.8 in.) but smaller than
5 cm (2 in.).
- T3: Tumor is larger than
5 cm (2 in.).
- T4: Tumor size varies but tumor has spread deeply into
muscle,
cartilage, or bone.
After the tumor (T) is staged, the TNM system stages
lymph node involvement (N) to help determine the
treatment options at each stage. Lymph node involvement is staged in the
following way:
- NX: Nearby (regional)
lymph nodes cannot be assessed.
- N0: Cancer
has not spread (metastasized) to nearby lymph nodes.
- N1: Cancer has spread to nearby lymph nodes.
The last part is to determine whether cancer has spread to other
parts of the body (metastasized). The TNM system stages metastasis (M) in the
following way:
- MX: The presence of
distant metastasis cannot be assessed.
- M0:
Cancer has not metastasized.
- M1: Cancer has
metastasized.
The TNM staging system allows your doctor to recommend the most
effective treatment options and discuss your long-term outcome (prognosis)
based on the type of tumor, the stage of the cancer, your age, and your overall
health.
The stage and TNM class are grouped in the following table.
Nonmelanoma skin cancer stage and
class| Stage | TNM class |
|---|
Stage 0 | |
Stage I | |
Stage II | |
Stage III | |
Stage IV | |